As of 2025-11-29, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -1.17 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.60 CAD, the upside of Medicenna Therapeutics Corp is -173.36%.
Based on its market price of 1.60 CAD and our intrinsic valuation, Medicenna Therapeutics Corp (MDNA.TO) is overvalued by 173.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.17 - -1.17 | -1.17 | -173.36% |
| P/E | (0.30) - 0.19 | 0.02 | -98.5% |
| DDM - Stable | (1.82) - (7.17) | (4.49) | -380.9% |
| DDM - Multi | (0.34) - (1.08) | (0.53) | -132.8% |
| Market Cap (mil) | 94.16 |
| Beta | 2.47 |
| Outstanding shares (mil) | 58.85 |
| Enterprise Value (mil) | 78.56 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.99% |
| Cost of Debt | 5.00% |
| WACC | 9.98% |